CBLL
CeriBell, Inc. · Healthcare · Medical Devices
Last
$18.66
−$0.73 (−3.76%) 4:00 PM ET
Prev close $19.39
Open $18.83
Day high $19.30
Day low $18.45
Volume 367,904
Avg vol 324,553
Mkt cap
$692.58M
P/E ratio
-12.69
FY Revenue
$89.06M
EPS
-1.47
Gross Margin
87.89%
Sector
Healthcare
AI report sections
CBLL
CeriBell, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+30% (Above avg)
Vol/Avg: 1.30×
RSI
40.52 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.01 (Strong)
MACD: 0.02 Signal: 0.01
Short-Term
-0.07 (Weak)
MACD: -0.43 Signal: -0.36
Long-Term
-0.17 (Weak)
MACD: -0.13 Signal: 0.04
Intraday trend score 39.50

Latest news

CBLL 2 articles Positive: 2 Neutral: 0 Negative: 0
Positive GlobeNewswire Inc. • Jane Chao, Ph.D.
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

Ceribell obtained FDA 510(k) clearance for its ClarityⓇ algorithm, becoming the first AI-powered point-of-care EEG technology capable of detecting electrographic seizures across all patient ages, from pre-term neonates to adults.

CBLL FDA clearance seizure detection neonatal care EEG monitoring AI algorithm
Sentiment note

Achieved significant FDA regulatory milestone, expanded technological capabilities, addressed critical unmet medical need in neonatal seizure detection

Positive GlobeNewswire Inc. • Ceribell, Inc.
Medtech Leader Erica Rogers Joins Ceribell Board of Directors

Medical technology company Ceribell announced the appointment of Erica Rogers to its Board of Directors, bringing over three decades of healthcare leadership experience to help expand nationwide access to their point-of-care EEG system.

CBLL BSX medical technology neurological conditions EEG board appointment
Sentiment note

Company is expanding leadership with an experienced executive, demonstrating strategic growth and potential for innovation

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal